SCHEDULE: Wasatch Advisors Reports 3.1% Stake in MacroGenics Inc.
Beneficial Ownership Report
Wasatch Advisors LP has filed an amended Schedule 13G, disclosing a 3.1% beneficial ownership stake in MacroGenics Inc. as of September 30, 2025.
Summary
- Wasatch Advisors LP beneficially owns 1,950,287 shares of MacroGenics Inc. common stock.
- This ownership represents 3.1% of MacroGenics Inc.'s outstanding common stock.
- Wasatch Advisors LP, classified as an investment adviser, holds sole voting power and sole dispositive power over all 1,950,287 shares.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of MacroGenics Inc.
Sentiment
Score: 6
Explanation: The filing indicates a significant institutional investor, Wasatch Advisors LP, maintains a 3.1% beneficial ownership stake in MacroGenics Inc. This passive investment, held in the ordinary course of business, suggests a degree of confidence from a professional investment adviser, which is generally a positive signal.
Positives
- An institutional investment adviser, Wasatch Advisors LP, holds a significant 3.1% stake, which can be viewed as a vote of confidence in MacroGenics Inc.
- The holding is for passive investment purposes in the ordinary course of business, indicating no activist intentions.
Future Outlook
This filing does not contain any forward-looking statements or guidance from MacroGenics Inc. or Wasatch Advisors LP regarding future performance or strategic direction.
Industry Context
This filing reflects a routine disclosure by an institutional investment adviser regarding its passive ownership stake in MacroGenics Inc., a publicly traded biotechnology company. Such disclosures are standard practice, providing transparency on significant institutional holdings within the market.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder, which can influence investor sentiment.
- Company Management: Awareness of a notable institutional investor's stake in the company.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of the event which required the filing of this statement. |
| 11/12/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
MacroGenics Inc, MGEN, Wasatch Advisors LP, Schedule 13G, beneficial ownership, institutional investor, equity stake, investment adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.